The disappearance of certain CDC data and guidelines from its website last week could hinder the ability or willingness of ...

On January 7, 2025, the U.S. Food and Drug Administration (“FDA” or “Agency”) released a long-awaited guidance titled, “Communications From Firms ...

The Philippine Food and Drug Administration (FDA) has met with officials from South Korea’s Ministry of Food and Drug Safety ...

The removal of FDA guidance on clinical trial diversity and related anti–diversity, equity, and inclusion (DEI) actions may hinder progress toward equitable health care, impacting workforce diversity, ...

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...

Neurocrine Biosciences Q4 earnings topped forecasts, but revenue slightly missed. Analysts see Ingrezza's long-term growth ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

Even those PEPFAR programs operating must limit distribution of preventive medication, according to apparent State Department ...

Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.

CFO Vanessa Kanu reported Q4 adjusted EBITDA of $195 million, representing a 9% increase year-over-year. She attributed the 27% increase in adjusted diluted EPS to strong margins and a lower tax rate ...